Guatemala Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in guatemala, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Healthcare
Last published date:

Overview

Guatemala’s healthcare system is divided between under-resourced public services and higher-cost private care. Most of the population relies on the public sector due to financial limitations, while the private sector is preferred for its quality, modern facilities, and advanced equipment, though it remains unaffordable for many.

Private healthcare providers prioritize high-performance medical equipment and reliable distributor support, with continued investment expected in diagnostics and technology. Public healthcare, managed by the Ministry of Health, IGSS, and the military, focuses on cost-efficiency and uses competitive bidding for procurement. However, corruption in public tenders poses challenges to transparency and supplier participation.

The sector is heavily reliant on imports, primarily from the U.S., China, India, and Mexico, with limited local pharmaceutical production focused on generics.

Healthcare spending is projected to grow steadily, with total financing expected to increase from USD 7.62B in 2025 to USD 10.02B by 2029 (+40%). Consumer healthcare spending alone is forecasted to rise from USD 4.89B to USD 6.2B (an increase of billion (+47%), reflecting increased demand for private services and a shift toward out-of-pocket expenditures.
 

 

2022

2023

2024

Total Imports

2,989,537.5

2,644,510.6

2,970,115.0

Total Exports

970,759.2

977,633.7

1,021,238.7

Imports from the US 

544,363.2

460,021.1

476,884.5

HS Chapters: 39, 30, 94, and 62.
Units: USD thousands
Source:  SIECA Guatemala, Central America Data

Leading Sub-sectors

Guatemala’s healthcare sector offers strong growth and investment potential across several key subsectors. Pharmaceuticals remain a leading area, driven by rising rates of chronic diseases (e.g., diabetes, cancer, hypertension) and growing demand for both generic and branded medications.

Medical devices and equipment are also in high demand as public and private institutions modernize infrastructure and expand diagnostic and surgical capabilities. Priority areas include diagnostic imaging, surgical instruments, and homecare products supporting chronic care and aging populations.

Clinical laboratory equipment is a particularly dynamic niche, with increased investment in advanced diagnostics—such as hematology analyzers, immunoassay systems, molecular diagnostics, and lab automation—driven by public health needs and private sector growth. Both public agencies (e.g., Ministry of Health, IGSS) and private labs are enhancing diagnostic capacity to support disease surveillance, maternal health, and chronic disease management.

Additional high-potential areas include private healthcare services for middle- and high-income populations, internationally supported public health initiatives, and the wellness and nutraceutical market, reflecting a growing focus on preventive care. These trends point to robust opportunities for companies entering or expanding in Guatemala’s healthcare market.

Opportunities

The Guatemalan government is prioritizing improvements to its public healthcare system, particularly in underserved rural areas with limited access to essential services. Many health facilities face outdated infrastructure, limited diagnostics, and medical supply shortages—creating significant opportunities for investment in medical equipment and digital health solutions.

Medical devices and clinical laboratory equipment are key growth areas, with strong demand from public hospitals and institutions like IGSS for imaging systems (ultrasound, X-ray, MRI), surgical tools, patient monitors, lab technologies (e.g., hematology analyzers, PCR testing). Both public and private labs are expanding capabilities to manage chronic and infectious diseases, driving interest in automated diagnostics and lab software.

Pharmaceuticals—especially generics for chronic conditions—also present opportunity. However, the market is highly price-sensitive, with strong competition from lower-cost suppliers in India, China, and the region. U.S. firms can differentiate through quality, reliability, after-sales service, and training.

Despite pricing challenges, Guatemala offers U.S. exporters a considerable export market and strategic entry point for the region if they can align with local budget realities and partner with public or private healthcare providers. Companies offering cost-effective, value-added solutions will be best positioned in this modernizing sector.

Web Resources

  • Statista: www.statista.com
  • Ministry of Public Health and Social Assistance (MSPAS):  www.maspas.gob.gt
  • Pan American Health Organization (PAHO): www.paho.org
  • World Bank data: https://data.worldbank.org/country/guatemala
  • National Statistics Institute (INE):  www.ine.gob.gt
  • Statistical information:  www.sec.sieca.int/

Information

Interested parties may contact Commercial Assistant Karla Salas at karla.salas@trade.gov for more information

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility